Taiwan has secured ten million doses of BioNTech's Covid-19 vaccine after long negotiations.
The Taiwanese companies Foxconn and TSMC agreed on Monday on a purchase agreement worth almost 300 million euros.
An agreement had previously been heavily politicized.
The Taiwanese government had tried to buy the vaccine directly from Biontech for months.
She had accused China that an agreement that was supposed to be signed at the beginning of the year failed under pressure from the People's Republic.
China, which regards Taiwan as a breakaway province, had rejected that.
In light of public pressure over the island's sluggish vaccination campaign, the Taiwanese government allowed Foxconn founder Terry Gou and semiconductor manufacturer TSMC to negotiate on their behalf.
They have now agreed on a contract with the Chinese Biontech partner Fosun Pharma.
Taiwan only wanted to negotiate directly with Biontech and declared that it would not trust vaccines from China.
In spring 2020, Fosun Pharma concluded a license agreement with Biontech for the development and marketing of the German company's vaccine in China, Hong Kong, Macau and Taiwan.
According to the Apple suppliers Foxconn and TSMC, the ten million vaccine doses are to be delivered directly from Germany to Taiwan.
The first doses of the vaccine are not expected before the end of September. The vaccine doses, of which Gou said five million each will be bought by Foxconn and TSMC, will be donated to Taiwan. "Biontech is delighted to be able to supply the people of Taiwan with vaccines that have been manufactured in the European Union," said CEO Ugur Sahin.